Matches in Nanopublications for { ?s ?p "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP653860.RADJv5FvID6ZWEgIpMyEJmERrWvTOmy5ka7EB-Af0QqMM130_assertion description "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653860.RADJv5FvID6ZWEgIpMyEJmERrWvTOmy5ka7EB-Af0QqMM130_provenance.
- NP423334.RAWgk-OFZ8fO7hcNZP6YGAMmislFto7Z5DX7eqYzvj_VI130_assertion description "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423334.RAWgk-OFZ8fO7hcNZP6YGAMmislFto7Z5DX7eqYzvj_VI130_provenance.
- NP233209.RAeEeaedO1qE_yRDKCQg_BwThcocJx_Y-WJtuKx5SuZ-w130_assertion description "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233209.RAeEeaedO1qE_yRDKCQg_BwThcocJx_Y-WJtuKx5SuZ-w130_provenance.
- NP508139.RAV3yY_ibAFnUZBrQboky0BgJuwpyU-ZS-pjYeLOqA4Rk130_assertion description "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508139.RAV3yY_ibAFnUZBrQboky0BgJuwpyU-ZS-pjYeLOqA4Rk130_provenance.
- NP453044.RA8IEMbb61g0uRMkj8I5lBChEfa3IqIvA1rcziRw7tZzo130_assertion description "[We have previously demonstrated that overexpressing Tam67, a dominant-negative (DN) form of cJun, blocks AP-1 activity and inhibits breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453044.RA8IEMbb61g0uRMkj8I5lBChEfa3IqIvA1rcziRw7tZzo130_provenance.